It seems counterintuitive that shorter crops can result in enhanced yields; but they are more resistant to high winds and other extreme weather events, writes Bayer’s Richard Lawrence.
The US startup embeds “living sensors” in seeds that can signal plant distress, helping to mitigate crop loss and over-reliance on pesticides.
In a world first, the GM crop – developed in the early 1990s to provide higher levels of vitamin A – was recently approved for commercial planting in the Philippines.
It could file its prospectus – seeking to raise a reported $10 billion at a $60 billion valuation – as soon as next week.
CRISPR is the best tool the EU has to achieve its ambitious agrifood sustainability goals. The bloc needs to keep that squarely in mind when regulating its use, write Rudi Ariaans and Ferdinand Los.
The Israeli startup combines AI-driven technology with exotic and ancient crop types to breed seeds with superior nutritional qualities.
The deal involving the St Louis-based startup – which is developing gene-edited and selectively bred versions of crops used in alt-protein and animal feed production – is the latest in a string of recent agrifoodtech SPAC mergers.
The Japanese government has affirmed its “determination” that Sanatech Seed’s new tomato will be regulated as a GE, rather than a GMO, product.
The Microsoft co-founder commented on the acquisitions for the first time since he and wife Melinda were revealed as the top private farmland owners in the US earlier this year.
Editor’s note: Ponsi Trivisvavet is CEO at Inari, a seed genetics startup based in Cambridge, Massachusetts. The views expressed in this guest article are the
Unfold launched in August with $30m in funding from Bayer and Temasek. John Purcell, CEO and Bayer’s former vegetable R&D chief, has had a busy few months.
The US startup has developed a non-GMO soybean with 50% more protein than conventional varieties with the hope of tapping into the plant-based alternatives market.
Named Unfold, the new venture has received $30 million in funding from the two companies, along with rights to germplasm from Bayer’s vegetable portfolio.
Sponsored
Novozymes wants your help to accelerate protein’s fungal future